|
|
|
|
|
by mlyle
1207 days ago
|
|
> instead of staying at the injection site. We've known that forever. There's been studies done with luciferase to see where the mRNA triggers protein production in small animals. We know that a big portion of the activity is in the liver, distant from the IM injection site (a lot of the activity is at the site, too). e.g.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624045/ "When mRNA-LNPs were injected intramuscularly and intratracheally, similar to intravenous and intraperitoneal deliveries, a large portion of the luciferase activity was detectable in the liver, demonstrating systemic spread of the nanoparticles." |
|